Jesus Gonzalez Bosquet, MD, PhD, discusses how machine learning could improve early ovarian cancer diagnosis by identifying methylated DNA in blood.

University of Iowa Health Care is the only place in Iowa offering a unique, minimally invasive technique for patients with pancreatic cancer.

The cancer’s reliance on a sugar metabolizing pathway may be an exploitable weakness.

Three early-career scientists have each been awarded a one-year, $40,000 American Cancer Society Institutional Research Grant through University of Iowa Holden Comprehensive Cancer Center.

Radiation has been a mainstay cancer therapy for almost 100 years. But its potent cell-killing power, so effective against tumors, is a double-edged sword when healthy tissue gets in the way.

Cancer Biology PhD student Travis Fischer has been selected for the University of Iowa's 2025 Dare to Discover campaign for his work in immunotherapies.

With support from a Holden Comprehensive Cancer Center pilot grant, a research team aims to improve the patient experience of the diagnostic period.

Four early-career scientists have each been awarded a one-year, $40,000 American Cancer Society Institutional Research Grant through University of Iowa Holden Comprehensive Cancer Center.

Trial will test whether a personalized mRNA vaccine combined with an immunotherapy prevents melanoma from recurring